Monday, August 18, 2014
Hooves@War: 100 Years Ago Today, a Farrier Enlisted in Western Australia
Welcome to the first in a series of articles to bring to life some of the lost names and faces of real people who served the hoofcare needs of horses during World War I, which began 100 years ago this month.
Friday, August 15, 2014
Video: How Does Dianne Volz of Equine Therapy 502 Help Keep Top Thoroughbreds Running?
Thursday, August 14, 2014
New Statistics: Lameness Most Critical Health Problem for British Horses; Laminitis Increased in 2014
A new study published today in Great Britain sorts out what is likely to send horses to vets and farriers for treatment there, and you have to look pretty far down to find hoof-related problems (other than laminitis) on the list.
Great Britain's National Equine Health Survey (NEHS), held annually every May, has confirmed for the second year that lameness is the most common syndrome affecting the UK’s horses and ponies. This year’s top results, compiled in this report, have also revealed an apparent increase in laminitis compared with previous years.
Monday, August 11, 2014
No Vacation for Laminitis: Brazilian Champion Bal a Bali Fights Disease in Florida
Just as the August "supermoon" was getting ready to rise on Sunday night, Fox Hill Farm sent out a chilling tweet. It said simply: "Bal a Bali fighting laminitis".
Sunday, August 10, 2014
Bigfoot on Course: Is Gatcombe's Best Shod Horse the Biggest Shod, Too?
Congratulations to British farrier Paul Conway, whose shoes were on Mulrys Error OBE, winner of the 2014 "Best Shod Horse" award at the British Festival of Eventing at Gatcombe Park last weekend. The judge couldn't miss this horse's feet.
Monday, July 28, 2014
Navicular Syndrome: Does FDA Approval of Tildren and Osphos Change Anything?
The landscape of treatment options for equine navicular syndrome is set to change this year, as the U.S. Food and Drug Agency (FDA) recently approved two drugs for use in the treatment of this complex lameness problem in the horse's foot. "Tildren" and "Osphos" are two specific medications that cleared the difficult hurdles of the FDA approval process in May 2014.
Subscribe to:
Posts (Atom)